Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8708960 | Sleep Medicine | 2018 | 31 Pages |
Abstract
HRQoL in NT1 patients improved after two years of follow-up. The use of sodium oxybate (Xyrem®) at follow-up was associated with increases in HRQoL. Psychiatric comorbidity was correlated with HRQoL at baseline but did not predict changes in HRQoL at follow-up.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Sebjørg Hesla Nordstrand, Berit Hjelde Hansen, Yusman Kamaleri, Kristian Bernhard Nilsen, Terje Rootwelt, Tor-Ivar Karlsen, Stine Knudsen,